GO:0003876 AMP deaminase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003876 AMP deaminase activity catalyzes the hydrolysis of AMP to IMP and ammonium, a key step in purine nucleotide catabolism.
• AMP deaminase activity is highly regulated by energy status and pH, and it influences ATP content and protein degradation in skeletal muscle.
• Altered AMP deaminase activity is linked to metabolic stress, diabetic cardiomyopathy, and neuromuscular disorders.
• The AMPD3 gene is a major determinant of AMP deaminase activity in heart and other organs, as shown by knockout mouse studies.
• AMP deaminase activity opposes AMPK signaling, affecting energy sensing and metabolic adaptation.
• CRISPR-based knockout, knock-in, and overexpression models enable precise dissection of AMP deaminase function in health and disease.
Description
AMP deaminase activity (GO:0003876) is a molecular function that catalyzes the irreversible deamination of adenosine monophosphate (AMP) to inosine monophosphate (IMP) and ammonium. This reaction is a central node in purine nucleotide metabolism, linking energy charge to the purine pool and influencing ATP homeostasis. The enzyme is particularly abundant in skeletal muscle, where it helps maintain the adenylate energy charge during contraction and acidosis. Beyond muscle, AMP deaminase activity is present in heart, liver, and other tissues, where it contributes to metabolic regulation and stress responses. Research on AMP deaminase activity has gained renewed attention because of its roles in metabolic diseases, muscle physiology, and postmortem metabolism. For example, increased AMP deaminase activity decreases ATP content and slows protein degradation in cultured skeletal muscle, suggesting a direct impact on muscle protein turnover. In diabetic cardiomyopathy, AMP deaminase activity is implicated in the pathological remodeling of cardiac energy metabolism. The enzyme also shows opposing activity changes with AMP-activated protein kinase (AMPK) during hibernation, highlighting its integration with energy-sensing pathways. Understanding AMP deaminase activity requires tools that can manipulate gene expression and enzyme function precisely. CRISPR-based gene editing enables the creation of knockout, point-mutation, knock-in, and overexpression cell models, which are essential for dissecting the causal roles of AMP deaminase in metabolic and disease processes. This article provides a research-grade overview of the GO term, its mechanisms, key genes, disease links, and experimental approaches.
AMP deaminase activity At A Glance
| GO ID | GO:0003876 |
|---|---|
| GO term | AMP deaminase activity |
| Ontology | molecular_function |
| Synonym | adenylate deaminase activity; AMP aminohydrolase activity; myoadenylate deaminase activity |
| Major function | Catalyzes the hydrolysis of AMP to IMP and ammonium, a key step in purine catabolism and energy charge regulation. |
| Reaction | AMP + H2O = IMP + NH4+ |
| Tissue distribution | Highly active in skeletal muscle, heart, liver, and other tissues |
| Regulation | Influenced by pH, energy status, and AMPK signaling |
| Disease relevance | Neuromuscular disorders, diabetic cardiomyopathy, metabolic stress |
What Is GO:0003876?
AMP deaminase activity (GO:0003876) is defined as the catalysis of the reaction AMP + H2O = IMP + NH4+. In other words, it is the enzyme activity that removes an amino group from AMP, converting it to IMP and releasing ammonium. This activity is synonymous with terms such as adenylate deaminase, AMP aminohydrolase, and myoadenylate deaminase activity. It is a molecular function that participates in purine nucleotide catabolism and energy metabolism.
Why Is AMP deaminase activity Important in Cell Biology?
AMP deaminase activity is important because it directly modulates the adenylate energy charge and purine nucleotide pool, which are critical for cellular ATP homeostasis and muscle function. Dysregulation of this activity has been observed in neuromuscular disorders, diabetic cardiomyopathy, and metabolic stress conditions, making it a potential therapeutic target. Moreover, its interplay with AMPK signaling positions AMP deaminase as a key regulator of energy sensing and metabolic adaptation.
• Regulates ATP content and protein degradation in skeletal muscle.
• Influences postmortem glycolysis and meat quality.
• Linked to neuromuscular disorders in childhood.
• Implicated in diabetic cardiomyopathy.
• Shows opposing activity to AMPK during hibernation.
• Modulated by acidosis in contracting fast-twitch muscle.
• AMPD3 knockout alters enzyme activity in heart and other organs.
• High-fat diet affects AMP deaminase and AMPK activity in heart.
• Potential target for metabolic and muscle-wasting conditions.
• Provides a model for studying purine nucleotide catabolism.
Molecular Mechanism of AMP deaminase activity
Substrate binding and catalysis
In simple terms: AMP deaminase grabs AMP and removes its amino group, turning it into IMP.
AMP deaminase activity catalyzes the hydrolytic deamination of AMP to IMP and ammonium. The enzyme binds AMP in its active site, where a water molecule attacks the purine ring, leading to the release of ammonium and formation of IMP. This reaction is irreversible under physiological conditions and is a key step in purine nucleotide catabolism.
Energy charge regulation
In simple terms: When energy is low, AMP builds up and AMP deaminase helps stabilize the energy balance.
AMP deaminase activity is sensitive to the cellular energy charge. During muscle contraction or metabolic stress, AMP levels rise, and AMP deaminase converts AMP to IMP, thereby reducing the adenylate pool and influencing ATP homeostasis. This activity helps maintain the adenylate energy charge and prevents excessive AMP accumulation.
pH dependence and acidosis
In simple terms: Acidosis can change how fast AMP deaminase works.
Acidosis influences AMP deaminase activity in contracting fast-twitch muscle, with studies showing that pH changes modulate the enzyme's catalytic rate. This pH sensitivity is important for understanding muscle fatigue and metabolic acidosis.
Interaction with AMPK signaling
In simple terms: AMP deaminase and AMPK compete for the same signal, AMP.
AMP deaminase activity opposes AMP-activated protein kinase (AMPK) signaling by consuming AMP. In hibernating ground squirrels, AMP deaminase and AMPK show opposing activity changes, suggesting a coordinated regulation of energy metabolism. Similarly, in high-fat diet-fed mice, AMP deaminase and AMPK activities are altered in the heart.
Tissue-specific isoforms and regulation
In simple terms: Different tissues use different versions of AMP deaminase.
AMP deaminase exists as multiple isoforms encoded by distinct genes, with AMPD3 being a major isoform in heart and other organs. Knockout of AMPD3 in mice alters enzyme activity in the heart and other tissues, demonstrating its role in tissue-specific regulation. The activity is also regulated by developmental and pathological states.
Key Genes Involved in GO:0003876 AMP deaminase activity
The following genes encode proteins with AMP deaminase activity or are directly involved in its regulation and metabolic context.
| Gene | Major Role | Research Relevance |
|---|---|---|
| AMPD1 | Muscle-specific AMP deaminase | Associated with myoadenylate deaminase deficiency and muscle metabolism |
| AMPD2 | Broadly expressed AMP deaminase | Involved in purine metabolism and metabolic regulation |
| AMPD3 | Heart and other tissue AMP deaminase | Knockout alters enzyme activity in heart and organs |
| PRKAA1 | AMPK catalytic subunit alpha 1 | Interacts with AMP deaminase in energy sensing |
| PRKAA2 | AMPK catalytic subunit alpha 2 | Opposing activity to AMP deaminase in hibernation |
| PRKAB1 | AMPK beta subunit | Regulates AMPK complex, affecting AMP deaminase interplay |
| PRKAG1 | AMPK gamma subunit | Senses AMP/ATP ratio, linked to AMP deaminase |
| GYS1 | Glycogen synthase | Downstream of energy metabolism affected by AMP deaminase |
| PFKM | Phosphofructokinase | Glycolysis enzyme influenced by AMP deaminase activity |
| TPI1 | Triosephosphate isomerase | Glycolytic enzyme in postmortem glycolysis |
| ENO3 | Beta-enolase | Muscle glycolysis, related to AMP deaminase effects |
| PKM | Pyruvate kinase | Glycolytic flux affected by AMP deaminase |
| LDHA | Lactate dehydrogenase A | Anaerobic metabolism linked to AMP deaminase |
| SLC2A4 | GLUT4 glucose transporter | Insulin-responsive, metabolic context |
| INS | Insulin | Diabetic cardiomyopathy relevance |
| MYH7 | Myosin heavy chain 7 | Cardiac muscle, affected in diabetic cardiomyopathy |
| ACTA1 | Actin alpha 1 | Skeletal muscle structure, related to AMP deaminase |
How Is AMP deaminase activity Regulated?
AMP deaminase activity is regulated at multiple levels. It is allosterically influenced by cellular energy charge, with AMP acting as both substrate and regulator. pH changes during acidosis modulate its activity in fast-twitch muscle. AMPK signaling opposes AMP deaminase by competing for AMP, and their activities are inversely correlated in hibernation and high-fat diet conditions. Additionally, tissue-specific expression of AMPD isoforms, such as AMPD3 in heart, contributes to differential regulation.
AMP deaminase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| AMPD1 | Myoadenylate deaminase deficiency | Knockout mouse or patient-derived myotubes |
| AMPD3 | Cardiac metabolic dysfunction | AMPD3 knockout mouse |
| AMPD2 | Diabetic cardiomyopathy | High-fat diet mouse model |
| PRKAA1/2 | Energy sensing disorders | AMPK knockout or knock-in cells |
| AMPD1 | Muscle wasting | Cultured skeletal muscle with overexpression |
Neuromuscular disorders
AMP deaminase activity in skeletal muscle is altered in various neuromuscular disorders in childhood, as shown by histochemical and biochemical studies. Reduced or absent activity is associated with myoadenylate deaminase deficiency, which can cause exercise intolerance and muscle weakness.
Diabetic cardiomyopathy
AMP deaminase activity plays a role in the pathogenesis of diabetic cardiomyopathy, where altered purine metabolism contributes to cardiac dysfunction. Targeting AMP deaminase may offer therapeutic benefits in diabetic heart disease.
Metabolic stress and muscle wasting
Increased AMP deaminase activity decreases ATP content and slows protein degradation in cultured skeletal muscle, linking it to muscle protein turnover and wasting conditions. This suggests that AMP deaminase inhibitors could modulate muscle mass.
Postmortem metabolism and meat quality
Altered AMP deaminase activity may extend postmortem glycolysis, affecting meat quality traits such as pH decline and color. This has implications for the meat industry and understanding of energy metabolism postmortem.
From AMP deaminase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of AMPD1 affect muscle AMP deaminase activity? | AMPD1 knockout mouse or CRISPR KO cell line |
| How does AMPD3 mutation affect cardiac function? | AMPD3 point-mutation knock-in mouse |
| Can overexpression of AMPD3 increase AMP deaminase activity? | AMPD3 overexpression cell model |
| What is the effect of AMP deaminase on ATP content? | Cultured skeletal muscle with AMPD overexpression |
| How does high-fat diet alter AMP deaminase and AMPK? | High-fat diet mouse model |
| Does acidosis change AMP deaminase activity? | Contracting fast-twitch muscle preparation |
How to Study the AMP deaminase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Spectrophotometric assay | AMP deaminase enzyme activity | Tissue homogenates, purified enzyme |
| HPLC | AMP, IMP, and ammonium levels | Metabolic flux studies |
| qRT-PCR | mRNA expression of AMPD genes | Tissue-specific expression |
| Western blot | Protein levels of AMP deaminase | Knockout validation |
| Immunohistochemistry | Tissue localization of AMP deaminase | Muscle biopsies |
| Metabolomics | Global purine nucleotide pools | Energy metabolism studies |
| CRISPR knockout | Loss-of-function of AMPD genes | Causal gene studies |
| Overexpression | Gain-of-function of AMPD genes | Enzyme activity increase |
Enzyme activity assays
AMP deaminase activity is typically measured by monitoring the conversion of AMP to IMP using spectrophotometric or HPLC-based methods. These assays can be applied to tissue homogenates or purified enzyme preparations.
Gene expression analysis
RNA-seq and qPCR can quantify AMPD1, AMPD2, and AMPD3 mRNA levels in different tissues and conditions. This helps link expression changes to enzyme activity.
Protein detection and localization
Western blotting and immunohistochemistry are used to detect AMP deaminase protein and its localization in muscle and heart tissues. Histochemical staining can reveal activity distribution.
Metabolic flux analysis
Stable isotope tracing and metabolomics can measure purine nucleotide fluxes and ATP/AMP ratios to assess AMP deaminase function in live cells.
How CRISPR Can Be Used to Study GO:0003876 AMP deaminase activity
Knockout
CRISPR knockout of AMPD1, AMPD2, or AMPD3 can abolish AMP deaminase activity, enabling studies of its role in muscle, heart, and other tissues. Knockout models help determine whether the enzyme is required for specific metabolic pathways.
Point Mutation
Point mutations can be introduced into the catalytic site of AMP deaminase to dissect residues critical for substrate binding or catalysis. Such models are useful for understanding enzyme kinetics and regulation.
Knock-in
Knock-in of tagged AMP deaminase (e.g., FLAG or GFP) allows for localization and interaction studies without altering endogenous regulation. This approach can also be used to express disease-associated variants.
Overexpression
Overexpression of AMPD genes in cell lines or tissues increases AMP deaminase activity, mimicking pathological states such as metabolic stress. This is useful for studying downstream effects on ATP and protein degradation.
How EDITGENE Supports AMP deaminase activity Research
Researchers studying AMP deaminase activity-related genes often need to determine whether a candidate gene is causally involved in metabolic or disease phenotypes. EDITGENE provides comprehensive CRISPR services to create precisely engineered cell and animal models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for AMP deaminase activity research.
Frequently Asked Questions About AMP deaminase activity
What is AMP deaminase activity?
AMP deaminase activity (GO:0003876) is the catalysis of AMP to IMP and ammonium, a key step in purine catabolism.
What genes are involved in AMP deaminase activity?
The main genes are AMPD1, AMPD2, and AMPD3, which encode different isoforms of AMP deaminase.
How is AMP deaminase activity regulated?
It is regulated by energy charge, pH, and AMPK signaling, and by tissue-specific expression of AMPD isoforms.
What diseases are associated with AMP deaminase activity?
Neuromuscular disorders, diabetic cardiomyopathy, and metabolic stress conditions.
What is the reaction catalyzed by AMP deaminase?
AMP + H2O = IMP + NH4+.
How can I measure AMP deaminase activity?
Using spectrophotometric or HPLC-based enzyme assays on tissue homogenates or purified enzyme.
What is the role of AMP deaminase in muscle?
It helps maintain the adenylate energy charge and influences ATP content and protein degradation.
Can AMP deaminase be targeted for therapy?
It is a potential target in diabetic cardiomyopathy and muscle wasting, but further research is needed.
What is the difference between AMPD1, AMPD2, and AMPD3?
They encode tissue-specific isoforms; AMPD1 is muscle-specific, AMPD3 is prominent in heart.
How does AMP deaminase interact with AMPK?
AMP deaminase consumes AMP, opposing AMPK activation, as seen in hibernation and high-fat diet studies.
Conclusion
AMP deaminase activity (GO:0003876) is a fundamental molecular function that links purine nucleotide catabolism to cellular energy status. Its dysregulation is implicated in muscle disorders, diabetic cardiomyopathy, and metabolic stress, making it a compelling target for research. CRISPR-based models offer powerful tools to dissect the causal roles of AMPD genes and to develop potential therapeutic strategies.
References
- 1. England EM et al.. 2015. Altered AMP deaminase activity may extend postmortem glycolysis.. Meat Sci 102:8-14 PMID: 25498483
- 2. Davis PR et al.. 2020. Increased AMP deaminase activity decreases ATP content and slows protein degradation in cultured skeletal muscle.. Metabolism 108:154257 PMID: 32370945
- 3. Nagao H et al.. 1986. AMP deaminase activity of skeletal muscle in neuromuscular disorders in childhood. Histochemical and biochemical studies.. Neuropediatrics 17(4):193-8 PMID: 3808228
- 4. Miura T et al.. 2024. Role of AMP deaminase in diabetic cardiomyopathy.. Mol Cell Biochem 479(12):3195-3211 PMID: 38386218
- 5. Lanaspa MA et al.. 2015. Opposing activity changes in AMP deaminase and AMP-activated protein kinase in the hibernating ground squirrel.. PLoS One 10(4):e0123509 PMID: 25856396
- 6. Dudley GA et al.. 1985. Influence of acidosis on AMP deaminase activity in contracting fast-twitch muscle.. Am J Physiol 248(1 Pt 1):C43-50 PMID: 3966542
- 7. Rybakowska I et al.. 2014. Effect of AMP-deaminase 3 knock-out in mice on enzyme activity in heart and other organs.. Nucleosides Nucleotides Nucleic Acids 33(4-6):319-22 PMID: 24940686
- 8. Rybakowska I et al.. 2014. Activity of AMP-regulated protein kinase and AMP-deaminase in the heart of mice fed high-fat diet.. Nucleosides Nucleotides Nucleic Acids 33(4-6):347-52 PMID: 24940692
